Wellington Shields Capital Management, LLC Kodiak Sciences Inc. Transaction History

Wellington Shields Capital Management, LLC

$558 Million
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.8 - $7.49 $21,600 - $89,880	-12,000 Reduced 7.26%	153,320 $275,000
Q2 2023 Aug 11, 2023	BUY	$4.3 - $9.48 $464,830 - $1.02 Million	108,100 Added 188.92%	165,320 $1.14 Million
Q4 2022 Feb 14, 2023	BUY	$6.52 - $8.05 $19,560 - $24,150	3,000 Added 5.53%	57,220 $409,000
Q3 2022 Nov 14, 2022	BUY	$7.57 - $12.5 $410,445 - $677,750	54,220 New	54,220 $420,000

Others Institutions Holding KOD

# of Institutions

Shares Held

39M

Call Options Held

6.5K

Put Options Held

5.8K

Baker Bros. Advisors LP New York, NY

17.3M
Shares

$95.7 Million
0.48% of portfolio
Black Rock Inc. New York, NY

3.85M
Shares

$21.3 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

1.95M
Shares

$10.8 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

1.69M
Shares

$9.32 Million
0.0% of portfolio
Iconiq Capital, LLC San Francisco, CA

1.02M
Shares

$5.62 Million
0.06% of portfolio

View Full List

About Kodiak Sciences Inc.

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $288M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

More about KOD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Shields Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Shields Capital Management, LLC with notifications on news.

Account